Pulmonary and Critical Care Medicine

Medicine & Life Sciences

1. Lung 100%
2. Idiopathic Pulmonary Fibrosis 43%
3. Interstitial Lung Diseases 42%
4. Granulomatosis with Polyangiitis 37%
5. Antineutrophil Cytoplasmic Antibodies 33%
6. Chronic Obstructive Pulmonary Disease 31%
7. Vasculitis 29%
8. Intensive Care Units 29%
9. Critical Illness 27%
10. Pneumocystis carinii 25%
11. Therapeutics 24%
12. Lung Neoplasms 23%
13. Mortality 23%
14. Lung Diseases 22%
15. Critical Care 21%
16. Adult Respiratory Distress Syndrome 21%
17. Thorax 20%
18. Pneumocystis 19%
19. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 19%
20. Acute Lung Injury 18%
21. Pneumonia 17%
22. Myeloblastin 17%
23. Artificial Respiration 17%
24. Sleep 16%
25. Transforming Growth Factors 15%
26. Cohort Studies 15%
27. Survival 15%
28. Biopsy 14%
29. Pneumocystis Pneumonia 14%
30. Mechanical Ventilators 14%
31. Liver Transplantation 14%
32. Rituximab 14%
33. Respiratory Insufficiency 14%
34. Pressure 13%
35. Infections 13%
36. Bronchiectasis 12%
37. Hepatopulmonary Syndrome 12%
38. Pulmonary Hypertension 12%
39. Neoplasms 12%
40. Dyspnea 12%
41. Asthma 11%
42. Confidence Intervals 11%
43. Population 11%
44. Fibrosis 11%
45. Systematic Reviews 11%
46. Coronavirus 10%
47. Lung Injury 10%
48. Hypertension 10%
49. Tomography 10%
50. Physicians 10%
51. Obstructive Sleep Apnea 10%
52. Bronchoscopy 10%
53. Adrenal Cortex Hormones 10%
54. Emphysema 10%
55. Microscopic Polyangiitis 10%
56. Sepsis 10%
57. Glucans 10%
58. Lymphangioleiomyomatosis 9%
59. Electronic Health Records 9%
60. Langerhans Cell Histiocytosis 9%
61. Transplants 9%
62. Lung Transplantation 9%
63. Odds Ratio 9%
64. Pulmonary Fibrosis 9%
65. Ventilation 9%
66. Hospital Mortality 9%
67. Alveolar Epithelial Cells 9%
68. Rheumatoid Arthritis 9%
69. Extrinsic Allergic Alveolitis 9%
70. Medicine 9%
71. T-Lymphocytes 8%
72. Guidelines 8%
73. Meta-Analysis 8%
74. Registries 8%
75. Quality of Life 8%
76. Sleep Apnea Syndromes 8%
77. Oxygen 8%
78. Epithelial Cells 8%
79. Transfusion-Related Acute Lung Injury 8%
80. Smokers 7%
81. Biomarkers 7%
82. Clinical Trials 7%
83. Hospitalization 7%
84. Incidence 7%
85. Virus Diseases 7%
86. Retrospective Studies 7%
87. Fibroblasts 7%
88. Respiratory System 7%
89. Adenocarcinoma of Lung 7%
90. Inflammation 7%
91. Transplant Recipients 7%
92. Recurrence 7%
93. Immunoglobulin G4-Related Disease 7%
94. Macrophages 7%
95. Cell Wall 7%
96. Randomized Controlled Trials 7%
97. Morbidity 7%
98. Wounds and Injuries 7%
99. Liver Diseases 7%